We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypotensive Effects of Conventional Dairy Products: Role of Arterial Stiffness

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01577030
First Posted: April 13, 2012
Last Update Posted: February 12, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Texas at Austin
  Purpose
Elevated systolic blood pressure is by far the largest single contributor to cardiovascular risks in middle-aged and older adults. Lifestyle modifications, including dietary modifications, are the first line approach for treating and preventing hypertension. The general aim of the proposed study is to address the efficacy of conventional dairy products as part of the normal routine diet for lowing arterial blood pressure in middle-aged and older adults with elevated blood pressure. The investigators hypothesize that the dietary intervention including dairy products will induce significant decreases in arterial blood pressure in this population. A secondary aim will be to test the hypothesis that these reductions in systolic blood pressure will be associated with increases in arterial stiffness/compliance and endothelial vasodilatory function.

Condition Intervention
Prehypertension Stage-1 Hypertension Dietary Supplement: Non-fat dairy Dietary Supplement: Add 4 servings fruit

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Hypotensive Effects of Conventional Dairy Products: Role of Arterial Stiffness

Resource links provided by NLM:


Further study details as provided by University of Texas at Austin:

Primary Outcome Measures:
  • Seated blood pressure [ Time Frame: 4 weeks ]

Secondary Outcome Measures:
  • 24-hour ambulatory blood pressure [ Time Frame: 4 weeks ]
  • Carotid arterial compliance [ Time Frame: 4 weeks ]
  • Arterial stiffness [ Time Frame: 4 weeks ]
  • Flow mediated dilation [ Time Frame: 4 weeks ]

Enrollment: 49
Study Start Date: January 2012
Study Completion Date: November 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Dairy
Add 4 daily servings of non-fat dairy to diet for a period of 4 weeks
Dietary Supplement: Non-fat dairy
Add 4 daily servings per day of non-fat dairy (yogurt, milk, cheese) for a period of 4 weeks
Active Comparator: Fruit
Add 4 daily servings of fruit to diet, remove all dairy from diet for a period of 4 weeks
Dietary Supplement: Add 4 servings fruit
Add 4 daily servings of fruit (fruit cup, apple sauce, orange juice) and remove all dairy for a period for 4 weeks

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Prehypertension or stage-1 hypertension

Exclusion Criteria:

  • Consume > 3 servings of dairy or fruit per day
  • Strenuous physical activity > 3 time per week
  • Lactose intolerance, pregnancy, lactation, and/or alcohol abuse
  • Taking cardiovascular-acting drugs
  • Overt cardiovascular disease, metabolic disease, GI disorders and/or renal disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01577030


Locations
United States, Texas
The University of Texas at Austin, Cardiovascular Aging Research Laboratory
Austin, Texas, United States, 78712
Sponsors and Collaborators
University of Texas at Austin
Investigators
Principal Investigator: Hirofumi Tanaka, PhD University of Texas at Austin
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Texas at Austin
ClinicalTrials.gov Identifier: NCT01577030     History of Changes
Other Study ID Numbers: LH002
First Submitted: April 10, 2012
First Posted: April 13, 2012
Last Update Posted: February 12, 2014
Last Verified: February 2014

Additional relevant MeSH terms:
Prehypertension
Vascular Diseases
Cardiovascular Diseases
Antihypertensive Agents